FDA advisers to weigh first psychedelic therapy in early June [2024]
…this will… be the first time in 25 years that the FDA will review a new treatment for PTSD…
The FDA is set to decide on the therapy’s fate by the middle of August [2024]… if rescheduled, then lobbying efforts will shift to individual states. Some have policies on the books that will immediately follow the DEA’s lead, while others will… pass new legislation greenlighting MDMA’s use.
Original Article (Fierce Biotech):
FDA advisers to weigh first psychedelic therapy in early June
Artwork Fair Use: Jwdietrich2
